The latest advocacy brief “Accelerating innovation and access to better medicines for children” by the Global Accelerator for Paediatric Formulations Network (GAP-f) is available on the WHO website. The objective of this brief is to mobilise global advocacy efforts to access better – safer, more effective and quality-assured – medicines in optimal formulations suitable for children. It outlines some of the main challenges in accelerating the development of and access to better medicines for children and presents possible solutions to address those challenges. This brief can be used to support the alignment, messaging, mobilisation and advocacy of stakeholders at global, regional and national levels.

The brief outlines the main challenges in accelerating the development and access to these medicines and presents 5 concrete solutions to address these challenges:

1️. Prioritise efforts: Focus on priority drugs and formulations in the pipeline through the Paediatric Drug Optimization (PADO) process.

2. Strengthen coordination: Improve coordination to align efforts, track needs, and ensure seamless funding streams for paediatric medicines.

3️. Incentivise action: Address regulatory challenges and facilitate market entry to boost R&D investments for paediatric medicines.

4️. Ensure accessibility: Accelerate the introduction and sustain access to better and affordable medicines for children by addressing policy updates, capacity building, and more.

5️. Invest more and smarter: Mobilise resources to accelerate R&D of better formulations for children, with an estimated $100M needed by 2030 to impact 16M children’s lives.

Access the brief